Cole Jeffrey Scott bought CVKD
October 9, 2026 · Form 4 insider transaction
Cole Jeffrey Scott bought 150,000 shares of Cadrenal Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
150,000
Price
$0.00
Total value
N/A
InsiderCole Jeffrey Scott
Role—
SecurityStock Option
Transaction codeA: Grant or award
Transaction dateOctober 9, 2026
Filing dateOctober 13, 2026
Shares owned after150,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The stock options have a grant date of October 9, 2026 under the Issuer's 2022 Successor Equity Incentive Plan, were fully vested and immediately exercisable on the date of grant, and have an exercise price equal to the closing price of the Issuer's common stock on October 9, 2026.